120 filings
Page 3 of 6
8-K
fhwln28k1lf7k8dy n6v
16 Sep 20
Verastem Oncology Announces Presentation of Updated Phase 1/2 FRAME Study Data at the 2nd Annual RAS-Targeted Drug Development Summit
8:47am
8-K
c5bur 74gj8
13 Aug 20
Departure of Directors or Certain Officers
4:11pm
8-K
h8yupi
10 Aug 20
Verastem Will Receive $70 Million Up-Front with Total Deal Value up to $311 Million, Plus Double-Digit Sales Royalties
8:30am
8-K
tmwowu5ycpyd1
21 May 20
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
7vc kszdol
27 Apr 20
Results of Operations and Financial Condition
9:16am
8-K
skyb kuysao
23 Apr 20
Verastem Oncology Appoints John H. Johnson to its Board of Directors
8:45am
8-K
pbvwo2krr w58xorflbf
8 Apr 20
Departure of Directors or Certain Officers
4:09pm
8-K
4e9ge155bwwq2e60
28 Feb 20
Verastem Oncology Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
6:13am
8-K
fnb3udb
13 Jan 20
Entry into a Material Definitive Agreement
6:03am
8-K
3icbn
20 Nov 19
Entry into a Material Definitive Agreement
3:18pm
8-K
zrkn6pxjwot t1
12 Nov 19
Entry into a Material Definitive Agreement
8:37am
8-K
qo0b99 q6frp9rtrfa
29 Oct 19
Verastem Oncology Reports Third Quarter 2019 Financial Results and Recent Company Progress
9:28pm
8-K
everqw8ytr7f6j f1e
1 Aug 19
Verastem Oncology Appoints Brian Stuglik as Chief Executive Officer
4:05pm
8-K
oxofnetz
29 Jul 19
Entry into a Material Definitive Agreement
4:15pm
8-K
ze705 wg6j
25 Jun 19
Verastem Oncology Announces Leadership Changes
5:11pm
8-K
7q2l6w7e74s
17 May 19
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
est0idw9 p5dq6l4jubo
23 Apr 19
Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility
4:20pm
8-K
egcdl3ya13c7 wicgsg
20 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:09pm
8-K
fx4ehh5 azys5zz
18 Oct 18
Verastem Oncology Announces Executive Leadership Appointments and Changes
4:12pm
8-K
5stvl
17 Oct 18
Entry into a Material Definitive Agreement
5:18pm